For the roughly one in ten people whose bodies never fully recovered from COVID-19, medicine has long offered little more than uncertainty. Now, researchers at Gladstone Institutes have identified something concrete: in long COVID patients, the immune cells designed to fight specific viruses bear the marks of both exhaustion and unusual destructive intensity — a paradox that may help explain why the body remains in a state of unresolved conflict long after the initial infection has passed. The discovery, which points especially toward herpesviruses and shows stronger effects in women, does not
EurekAlert!
· Jul 31, 2026
· health
· 7 min de leitura
High
Apuração: Verificado
Long COVID linked to exhausted, hyperactive immune cells targeting multiple viruses
Long COVID significantly impacts patients' quality of life, forcing some to leave work and abandon pre-COVID lifestyles due to severe, unpredictable symptoms lasting months or years.
◉
Health & Medicine
6892 artigos relacionados
Researchers uncover how bacteria survive antibiotics through tolerance…
News-Medical · 100% correspondência
Mix-and-match COVID boosters offer immune system flexibility, expert e…
The Conversation · 99% correspondência
FDA poised to approve scaled COVID vaccine for children ages 5-11
Futurity: Research News · 99% correspondência
Context matters: Why vaccinated people dominate COVID hospital numbers
The Canberra Times · 99% correspondência
Pharma M&A Surge Amid Drug Price Scrutiny, Bird Flu Vaccination Push
Devdiscourse · 99% correspondência
Cobertura Relacionada
Manistee News Advocate · Aug 01
Synthetic molecules show promise in blocking Parkinson's protein clumps in mice
Researchers developed SK-129, a synthetic foldamer molecule that blocks toxic alpha-synuclein protein clumping in mouse …
Mirage News · Aug 01 Hospital Misconceptions About Early Milk Production Undermine Breastfeeding SuccessA peer-reviewed evidence review identifies three widespread clinical misconceptions in maternity wards—about colostrum s…
Nature · Aug 01 Drones Cut Cancer Surgery Specimen Transport Time by 70% in Indian Hospital TrialA pilot study in India demonstrated that drones can safely transport temperature-sensitive cancer surgery specimens betw…
The National Provisioner · Aug 01 Gene Editing Emerges as Agriculture's Next Essential ToolCRISPR gene editing is moving from laboratory concept to commercial reality, with applications ranging from seedless bla…
Viés e Enquadramento
⚖
Science reporting on long COVID immune mechanisms with appropriate emphasis on research findings and patient impact, minimal detectable bias.
Bias Direction
center
Confidence
HIGH
Balanced scientific journalism presenting research findings with contextual patient impact; uses expert authority (researcher interview) to establish credibility; frames long COVID as serious public health issue requiring research solutions.
Extreme fatigue
racing pulse
brain fog
entire lives turned upside down
heartbreaking ways
Perspectives from long COVID patients themselves (only paraphrased through researcher)
Viewpoints from healthcare providers treating long COVID patients
Economic/epidemiological data on long COVID burden
Perspectives questioning the prevalence estimates or severity claims
Information on ongoing clinical trials or alternative treatment approaches
Impacto Geopolítico
🌎
Medical research on long COVID immune dysfunction has no direct geopolitical implications; this is a public health discovery unrelated to international relations or power dynamics.
Escalation Risk
low
Confidence
HIGH
Lente Econômica
📈
Long COVID research reveals immune dysfunction affecting millions, with potential economic impacts on healthcare costs, workforce productivity, and pharmaceutical development opportunities.
Market Signal
mixed
Confidence
MED
Healthcare and medical services
Pharmaceutical and biotechnology
Life insurance and disability insurance
Labor and workforce productivity
Mental health services
Medical research and diagnostics
Households face ongoing healthcare expenses without proven treatments, potential loss of income from work absences/disability, increased insurance premiums, and psychological burden. WHO estimates ~10% of COVID cases develop long COVID, affecting millions globally with extended treatment needs.
Governments may increase funding for long COVID research and treatment development; healthcare systems need protocols for diagnosis and management; disability and workers' compensation policies may require updates; pharmaceutical companies face regulatory incentives for therapeutic development; public health agencies must address workforce impact and healthcare burden.